StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI - Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday.
Other analysts also recently issued research reports about the stock. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th. Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $168.67.
Get Our Latest Analysis on ICUI
ICU Medical Stock Down 5.8 %
Shares of NASDAQ ICUI traded down $8.28 during trading on Friday, hitting $133.97. The stock had a trading volume of 443,064 shares, compared to its average volume of 267,455. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a fifty day moving average of $149.63 and a two-hundred day moving average of $161.69. ICU Medical has a 12 month low of $93.36 and a 12 month high of $196.26. The company has a market capitalization of $3.28 billion, a PE ratio of -29.32 and a beta of 0.86.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of ICUI. Harvest Fund Management Co. Ltd purchased a new position in shares of ICU Medical during the fourth quarter valued at about $33,000. Quarry LP boosted its position in ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp purchased a new position in shares of ICU Medical during the 4th quarter worth approximately $52,000. Venturi Wealth Management LLC raised its position in shares of ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the period. Hedge funds and other institutional investors own 96.10% of the company's stock.
About ICU Medical
(
Get Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Read More
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
